iBio, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell iBio, Inc. and other ETFs, options, and stocks.About IBIO
iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets.
CEOMartin B. Brenner
CEOMartin B. Brenner
Employees20
Employees20
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1993
Founded1993
Employees20
Employees20
IBIO Key Statistics
Market cap44.08M
Market cap44.08M
Price-Earnings ratio-1.74
Price-Earnings ratio-1.74
Dividend yield—
Dividend yield—
Average volume24.52M
Average volume24.52M
High today$2.46
High today$2.46
Low today$1.84
Low today$1.84
Open price$2.35
Open price$2.35
Volume4.94M
Volume4.94M
52 Week high$6.89
52 Week high$6.89
52 Week low$0.5562
52 Week low$0.5562
Stock Snapshot
With a market cap of 44.08M, iBio, Inc.(IBIO) trades at $1.96. The stock has a price-to-earnings ratio of -1.74.
On 2025-12-12, iBio, Inc.(IBIO) stock moved within a range of $1.84 to $2.46. With shares now at $1.96, the stock is trading +6.5% above its intraday low and -20.3% below the session's peak.
Trading volume for iBio, Inc.(IBIO) stock has reached 4.94M, versus its average volume of 24.52M.
Over the past 52 weeks, iBio, Inc.(IBIO) stock has traded between a high of $6.89 and a low of $0.56.
Over the past 52 weeks, iBio, Inc.(IBIO) stock has traded between a high of $6.89 and a low of $0.56.
People also own
Based on the portfolios of people who own IBIO. This list is generated using Robinhood data, and it’s not a recommendation.